Study of Glucarpidase (CPG2) for the Management of Patients With Delayed Methotrexate Clearance
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- BTG International Inc.
- Registration Number
- NCT00219791
- Locations
- 🇩🇪
Charite - Universitätsmedizin Berlin, Berlin, Germany
Efficacy Study of Digibind for Treatment of Severe Preeclampsia
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- BTG International Inc.
- Target Recruit Count
- 51
- Registration Number
- NCT00158743
- Locations
- 🇺🇸
University of South Alabama, Mobile, Alabama, United States
🇺🇸Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, PO Box 33932, 1501 Kings Highway, Shreveport, Louisiana, United States
🇺🇸Department of OB-GYN, Division of Maternal Fetal Medicine, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath